Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metaboliteGiorgia Renga, Claudio Costantini, Giuseppe Pieraccini et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 129
CPX-351 exploits the gut microbiota to promote mucosal barrier function, colonization resistance, and immune homeostasisGiorgia Renga, Luigina Romani, Vasileios Oikonomou et al.|Blood|2024Cited by 30